Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2022-03-07 02:51:54 UTC |
---|
HMDB ID | HMDB0015201 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Clonazepam |
---|
Description | Clonazepam, also known as klonopin or rivotril, belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. It is used in the treatment of all types of epilepsy and seizures, as well as myoclonus and associated abnormal movements, and panic disorders. Clonazepam is a moderately basic compound (based on its pKa). Clonazepam is a potentially toxic compound. 1,3-Dihydro-2H-1,4-benzodiazepin-2-one in which the hydrogens at positions 5 and 7 are substituted by 2-chlorophenyl and nitro groups, respectively. However, its use can be limited by the development of tolerance and by sedation. |
---|
Structure | [O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1 InChI=1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20) |
---|
Synonyms | Value | Source |
---|
1,3-Dihydro-7-nitro-5-(2-chlorophenyl)-2H-1,4.benzodiazepin-2-one | ChEBI | 5-(2-Chloro-phenyl)-7-nitro-1,3-dihydro-benzo[e][1,4]diazepin-2-one | ChEBI | 5-(2-Chlorophenyl)-7-nitro-1H-benzo[e][1,4]diazepin-2(3H)-one | ChEBI | 5-(O-Chlorophenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-one | ChEBI | Clonazepamum | ChEBI | Klonopin | Kegg | Clonazepam fine granules | HMDB | Clonazepam tablets | HMDB | Chlonazepam | HMDB | Rivotril | HMDB | Antelepsin | HMDB |
|
---|
Chemical Formula | C15H10ClN3O3 |
---|
Average Molecular Weight | 315.711 |
---|
Monoisotopic Molecular Weight | 315.041068908 |
---|
IUPAC Name | 5-(2-chlorophenyl)-7-nitro-2,3-dihydro-1H-1,4-benzodiazepin-2-one |
---|
Traditional Name | clonazepam |
---|
CAS Registry Number | 1622-61-3 |
---|
SMILES | [O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2Cl)C=C1 |
---|
InChI Identifier | InChI=1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20) |
---|
InChI Key | DGBIGWXXNGSACT-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | 1,4-benzodiazepines |
---|
Direct Parent | 1,4-benzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - 1,4-benzodiazepine
- Nitroaromatic compound
- Chlorobenzene
- Halobenzene
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Cyclic carboximidic acid
- Ketimine
- C-nitro compound
- Organic nitro compound
- Allyl-type 1,3-dipolar organic compound
- Azacycle
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Organic oxoazanium
- Organic oxygen compound
- Organochloride
- Organonitrogen compound
- Organohalogen compound
- Organic nitrogen compound
- Imine
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organooxygen compound
- Organic zwitterion
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 236.5 - 238.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.011 g/L | Not Available | LogP | 2.7 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross SectionsAdduct Type | Data Source | CCS Value (Å2) | Reference |
---|
[M+H]+ | CBM | 168.2 | 30932474 |
|
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Clonazepam,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)CN=C(C2=CC=CC=C2Cl)C2=CC([N+](=O)[O-])=CC=C21 | 2692.9 | Semi standard non polar | 33892256 | Clonazepam,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)CN=C(C2=CC=CC=C2Cl)C2=CC([N+](=O)[O-])=CC=C21 | 2717.8 | Standard non polar | 33892256 | Clonazepam,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)CN=C(C2=CC=CC=C2Cl)C2=CC([N+](=O)[O-])=CC=C21 | 3980.3 | Standard polar | 33892256 | Clonazepam,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)CN=C(C2=CC=CC=C2Cl)C2=CC([N+](=O)[O-])=CC=C21 | 2926.8 | Semi standard non polar | 33892256 | Clonazepam,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)CN=C(C2=CC=CC=C2Cl)C2=CC([N+](=O)[O-])=CC=C21 | 2901.6 | Standard non polar | 33892256 | Clonazepam,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)CN=C(C2=CC=CC=C2Cl)C2=CC([N+](=O)[O-])=CC=C21 | 3999.5 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Clonazepam GC-MS (Non-derivatized) - 70eV, Positive | splash10-02br-1190000000-1354614c337562e212cc | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clonazepam GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Clonazepam GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | MS | Mass Spectrum (Electron Ionization) | splash10-02a9-2492000000-109e2626e8a128b9e433 | 2014-09-20 | Not Available | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clonazepam 10V, Positive-QTOF | splash10-014i-0009000000-f625038036279ea1ad02 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clonazepam 20V, Positive-QTOF | splash10-014i-0049000000-4dfcaef6e6f274ea9b0a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clonazepam 40V, Positive-QTOF | splash10-0a59-8911000000-fe9a4a8a76c224b6cb90 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clonazepam 10V, Negative-QTOF | splash10-03di-0009000000-cd9167e21ef0d5b8f888 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clonazepam 20V, Negative-QTOF | splash10-03di-0009000000-f28067a73f446175adef | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Clonazepam 40V, Negative-QTOF | splash10-0006-9000000000-ab88c27eceb0f144d9c2 | 2016-08-03 | Wishart Lab | View Spectrum |
|
---|
General References | - Earley JV, Fryer RI, Ning RY: Quinazolines and 1,4-benzodiazepines. LXXXIX: Haptens useful in benzodiazepine immunoassay development. J Pharm Sci. 1979 Jul;68(7):845-50. [PubMed:458601 ]
- Dreifuss FE, Penry JK, Rose SW, Kupferberg HJ, Dyken P, Sato S: Serum clonazepam concentrations in children with absence seizures. Neurology. 1975 Mar;25(3):255-8. [PubMed:1089913 ]
- Rosen GM, Turner MJ 3rd: Synthesis of spin traps specific for hydroxyl radical. J Med Chem. 1988 Feb;31(2):428-32. [PubMed:2828624 ]
- Rosen GM, Demos HA, Rauckman EJ: Not all aromatic nitro compounds form free radicals. Toxicol Lett. 1984 Aug;22(2):145-52. [PubMed:6089382 ]
- Robertson MD, Drummer OH: Postmortem drug metabolism by bacteria. J Forensic Sci. 1995 May;40(3):382-6. [PubMed:7782744 ]
|
---|